newsfilter
← Latest News
GlobeNewswire·

Evaxion announce 2026 financial calendar

COPENHAGEN, Denmark, November 12, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces its financial calendar for